Navigation Links
Omeros to Present at Deutsche Bank Securities Health Care Conference
Date:5/2/2012

SEATTLE, May 2, 2012 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation, bleeding and disorders of the central nervous system, today announced that Gregory A. Demopulos, M.D., chairman and chief executive officer, is scheduled to present at the Deutsche Bank Securities 37th Annual Health Care Conference next week. The presentation is scheduled for 10:00 a.m. Eastern Time on Wednesday, May 9, 2012.

The presentation will be webcast. The live and archived webcasts can be accessed on the "Events" page of the Company's website at www.omeros.com.  

About Omeros Corporation
Omeros is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products targeting inflammation, coagulopathies and disorders of the central nervous system. The Company's most clinically advanced product candidates are derived from its proprietary PharmacoSurgery™ platform designed to improve clinical outcomes of patients undergoing a wide range of surgical and medical procedures. Omeros has four ongoing clinical development programs. Omeros may also have the near-term capability, through its GPCR program, to add a large number of new drug targets and their corresponding compounds to the market. Behind its clinical candidates and GPCR platform, Omeros is building a diverse pipeline of protein and small-molecule preclinical programs targeting inflammation, coagulopathies and central nervous system disorders.


'/>"/>
SOURCE Omeros Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Omeros Names Dr. Patrick Gray as Scientific Fellow
2. Omeros to Present at the Cowen and Company 32nd Annual Health Care Conference
3. BioMed Realty and Omeros Sign New 64,500 Square Foot Lease in Seattle
4. Omeros Announces Submission to European Medicines Agency of Paediatric Investigation Plan Letter of Intent for OMS302
5. Omeros to Present at 23rd Annual Piper Jaffray Health Care Conference
6. Omeros Announces First Patients Treated in Phase 3 Clinical Program Evaluating OMS302
7. Omeros Unlocks Four Additional Orphan GPCRs
8. Omeros Unlocks Orphan GPCRs Linked to Leukemia and Sleep Disorders
9. Omeros Reports Allowance of Additional Patent for Arthroscopic Product
10. Omeros Announces Clinical Development Programs for OMS103HP and OMS302
11. Omeros Corporation Reports First Quarter 2011 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... DUBLIN , May 4, 2016 /PRNewswire/ ... the addition of the  "Global Acute Ischemic ... 2016"  report to their offering.  ... Global Acute Ischemic Stroke Market ... insights into Acute Ischemic Stroke pipeline products, ...
(Date:5/3/2016)... 3, 2016 BioNovus Innovations LLC and ... Advancing Medical Innovation (IAMI) today announced a new ... and medical devices. An agreement between ... to license, develop and commercialize medical innovations advanced ... "This partnership represents a significant advance in our ...
(Date:5/3/2016)... May 3, 2016   BIOTRONIK , a ... announced Food and Drug Administration (FDA) approval of ... provides heart failure patients with access to diagnostic ... have remote monitoring with daily automatic transmission and ... rate in response to physiological demands. ...
Breaking Medicine Technology:
(Date:5/5/2016)... (PRWEB) , ... May 05, 2016 , ... ... Behavioral Health Population Management Platform, announced today that Enlightened Solutions has joined the ... ability to optimize the care continuum for their patients being treated for substance ...
(Date:5/5/2016)... ... ... Liposuction specialist Marcia V. Byrd, MD spoke last month at the Fat ... Louis Airport Hotel. This year’s conference was titled “Living with Lipedema and Dealing with ... in treating Lipedema. Dr. Byrd is considered one of the leading physicians in the ...
(Date:5/5/2016)... ... 2016 , ... Nepenthe Laboratory Services (NLS), a premier drug monitoring and toxicology ... food item donations for Food for Lane County, and to help support awareness for ... of the assembly was to create an exciting atmosphere for the kids at Riverbend ...
(Date:5/5/2016)... Augusta, Kansas (PRWEB) , ... May 05, 2016 , ... ... management for its school nurses. This partnership will enable school health offices to streamline ... located in Butler County, Kansas, just east of Wichita. Augusta public schools serve 2,300 ...
(Date:5/5/2016)... ... May 05, 2016 , ... In an effort to ... a public health promotion and research organization, declared May as “National Sunshine Month.” ... other shifts in cultural behavior over the past several decades, Americans spend more ...
Breaking Medicine News(10 mins):